FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3085442992> ?p ?o ?g. }

• W3085442992 endingPage "3693" @default.
• W3085442992 startingPage "3685" @default.
• W3085442992 abstract "Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is characterized by complex pathophysiology including an impaired diastolic reserve. We recently showed that milrinone favourably modifies filling pressures at rest and during exertion in HFpEF patients; however, the responsible mechanism is uncertain. The objective of this study was to develop a clearer understanding of the acutely modifiable physiologic parameters that may be targeted in HFpEF. Methods and results We conducted computer modelling simulations based on invasive haemodynamic assessments, by right heart catheterization, in HFpEF patients at baseline and in response to milrinone. Our aim was to develop a detailed understanding of the physiologic mechanisms, which accounted for the observed actions. The resultant circulatory model of HFpEF encompassed the left ventricular (LV) end‐systolic and end‐diastolic pressure–volume relations, together with stressed blood volume, heart rate, and arterial mechanics. To support the modelled action of milrinone, we conducted complementary LV conductance catheter and echocardiography studies in sheep to evaluate LV end‐systolic and end‐diastolic pressure–volume relations. In HFpEF patients, the acute haemodynamic effects of intravenous milrinone ( n = 10) administration compared with placebo ( n = 10) included significant reductions in right atrial pressure (7 ± 1 to 3 ± 1 mmHg, P < 0.001) and pulmonary capillary wedge pressure (13 ± 1 to 8 ± 1 mmHg, P < 0.001), while cardiac index increased (2.77 ± 0.19 to 3.15 ± 0.14 L/min/m 2 , P < 0.05), and mean arterial pressure remained unchanged (95 ± 2 to 93 ± 3 mmHg, P = not significant). Computer simulations showed that these haemodynamic effects were explained by a concomitant 31% reduction in stressed blood volume together with 44% increase in LV end‐systolic elastance (LV E es ). Individually, changes in these parameters were not sufficient to explain the haemodynamic effects of milrinone. In vivo studies conducted in sheep ( n = 5) showed that milrinone reduced LV filling pressure (8.0 ± 0.8 to 2.7 ± 0.6 mmHg, P < 0.01) and increased LV E es (0.96 ± 0.07 to 2.07 ± 0.49, P < 0.05), while no significant effect on LV stiffness was observed (0.038 ± 0.003 to 0.034 ± 0.008, P = not significant). Conclusions These data demonstrate that stressed blood volume in HFpEF represents a relevant physiologic target in HFpEF; however, concomitant modulation of other cardiovascular parameters including LV contractility may be required to achieve desirable haemodynamic effects." @default.
• W3085442992 created "2020-09-21" @default.
• W3085442992 creator A5003092595 @default.
• W3085442992 creator A5027983406 @default.
• W3085442992 creator A5046319923 @default.
• W3085442992 creator A5067861798 @default.
• W3085442992 creator A5081840878 @default.
• W3085442992 date "2020-09-09" @default.
• W3085442992 modified "2023-10-18" @default.
• W3085442992 title "Identification of physiologic treatment targets with favourable haemodynamic consequences in heart failure with preserved ejection fraction" @default.
• W3085442992 cites W1968217945 @default.
• W3085442992 cites W1975476355 @default.
• W3085442992 cites W1989500574 @default.
• W3085442992 cites W1991463267 @default.
• W3085442992 cites W1991875014 @default.
• W3085442992 cites W2001148247 @default.
• W3085442992 cites W2013403532 @default.
• W3085442992 cites W2021121384 @default.
• W3085442992 cites W2047288521 @default.
• W3085442992 cites W2058028313 @default.
• W3085442992 cites W2104461741 @default.
• W3085442992 cites W2105380741 @default.
• W3085442992 cites W2105400632 @default.
• W3085442992 cites W2131576310 @default.
• W3085442992 cites W2153809726 @default.
• W3085442992 cites W2166504467 @default.
• W3085442992 cites W2199352458 @default.
• W3085442992 cites W2295625255 @default.
• W3085442992 cites W2318892216 @default.
• W3085442992 cites W2395318415 @default.
• W3085442992 cites W2398072751 @default.
• W3085442992 cites W2554655675 @default.
• W3085442992 cites W2803950132 @default.
• W3085442992 cites W2804511116 @default.
• W3085442992 cites W2806788216 @default.
• W3085442992 cites W2887223866 @default.
• W3085442992 cites W2899687631 @default.
• W3085442992 cites W2912362952 @default.
• W3085442992 cites W2920988382 @default.
• W3085442992 cites W2945334580 @default.
• W3085442992 cites W2947418437 @default.
• W3085442992 cites W2964755609 @default.
• W3085442992 cites W2970357473 @default.
• W3085442992 cites W2983894956 @default.
• W3085442992 cites W3014160396 @default.
• W3085442992 doi "https://doi.org/10.1002/ehf2.12908" @default.
• W3085442992 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7754909" @default.
• W3085442992 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32902205" @default.
• W3085442992 hasPublicationYear "2020" @default.
• W3085442992 type Work @default.
• W3085442992 sameAs 3085442992 @default.
• W3085442992 citedByCount "7" @default.
• W3085442992 countsByYear W30854429922021 @default.
• W3085442992 countsByYear W30854429922022 @default.
• W3085442992 countsByYear W30854429922023 @default.
• W3085442992 crossrefType "journal-article" @default.
• W3085442992 hasAuthorship W3085442992A5003092595 @default.
• W3085442992 hasAuthorship W3085442992A5027983406 @default.
• W3085442992 hasAuthorship W3085442992A5046319923 @default.
• W3085442992 hasAuthorship W3085442992A5067861798 @default.
• W3085442992 hasAuthorship W3085442992A5081840878 @default.
• W3085442992 hasBestOaLocation W30854429921 @default.
• W3085442992 hasConcept C126322002 @default.
• W3085442992 hasConcept C139940330 @default.
• W3085442992 hasConcept C146556889 @default.
• W3085442992 hasConcept C164705383 @default.
• W3085442992 hasConcept C178853913 @default.
• W3085442992 hasConcept C2776645727 @default.
• W3085442992 hasConcept C2777099384 @default.
• W3085442992 hasConcept C2777953023 @default.
• W3085442992 hasConcept C2778198053 @default.
• W3085442992 hasConcept C31861589 @default.
• W3085442992 hasConcept C35207712 @default.
• W3085442992 hasConcept C48277249 @default.
• W3085442992 hasConcept C57900726 @default.
• W3085442992 hasConcept C71924100 @default.
• W3085442992 hasConcept C78085059 @default.
• W3085442992 hasConcept C84393581 @default.
• W3085442992 hasConceptScore W3085442992C126322002 @default.
• W3085442992 hasConceptScore W3085442992C139940330 @default.
• W3085442992 hasConceptScore W3085442992C146556889 @default.
• W3085442992 hasConceptScore W3085442992C164705383 @default.
• W3085442992 hasConceptScore W3085442992C178853913 @default.
• W3085442992 hasConceptScore W3085442992C2776645727 @default.
• W3085442992 hasConceptScore W3085442992C2777099384 @default.
• W3085442992 hasConceptScore W3085442992C2777953023 @default.
• W3085442992 hasConceptScore W3085442992C2778198053 @default.
• W3085442992 hasConceptScore W3085442992C31861589 @default.
• W3085442992 hasConceptScore W3085442992C35207712 @default.
• W3085442992 hasConceptScore W3085442992C48277249 @default.
• W3085442992 hasConceptScore W3085442992C57900726 @default.
• W3085442992 hasConceptScore W3085442992C71924100 @default.
• W3085442992 hasConceptScore W3085442992C78085059 @default.
• W3085442992 hasConceptScore W3085442992C84393581 @default.
• W3085442992 hasFunder F4320334705 @default.
• W3085442992 hasIssue "6" @default.
• W3085442992 hasLocation W30854429921 @default.
• W3085442992 hasLocation W30854429922 @default.

• next